Trial record 78 of 115 for: "Viral Infectious Disease" | "Ledipasvir"
Comparative Efficacy of Fixed-dose Combination Sofosbuvir + Ledipasvir, 8 vs. 12 Weeks in Chronic Hepatitis C Genotype 6
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02480166|
Recruitment Status : Completed
First Posted : June 24, 2015
Results First Posted : September 19, 2017
Last Update Posted : September 19, 2017
Information provided by (Responsible Party):
Mindie H. Nguyen, Stanford University
|Study Design||Allocation: Non-Randomized; Intervention Model: Parallel Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
Drug: 8 weeks SOF/LED
Drug: 12 weeks SOF/LED
Our population was small and our study was not powered to be able to determine significant differences between groups.